Ysios Capital Partners
@ysioscapital.bsky.social
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.
Sign up & stay tuned http://eepurl.com/duXVDv 📩
Sign up & stay tuned http://eepurl.com/duXVDv 📩
Pinned
📢 #PortfolioNews | Excited to share the strategic deal of our #portfolio company #VarmX with #CSL 💊
🔹Up to $2.2B incl. $117m upfront & milestones
🔹Global Phase 3 of VMX-C001 fully funded
🌍Step closer to market for a major unmet need
👉 buff.ly/aO4iHwV
#YsiosPortfolio #vc
🔹Up to $2.2B incl. $117m upfront & milestones
🔹Global Phase 3 of VMX-C001 fully funded
🌍Step closer to market for a major unmet need
👉 buff.ly/aO4iHwV
#YsiosPortfolio #vc
📢 #YsiosTeam | We are delighted to announce the promotion of Almudena Méndez and Sriram Balusu to #Associate at
@ysioscapital.bsky.social ! 🎉
👏 Congratulations, very well deserved!
🙋♀️ Meet Almudena lnkd.in/dSrMw4Ya
🙋 Meet Sriram: bit.ly/SriramB
#vc #talent
@ysioscapital.bsky.social ! 🎉
👏 Congratulations, very well deserved!
🙋♀️ Meet Almudena lnkd.in/dSrMw4Ya
🙋 Meet Sriram: bit.ly/SriramB
#vc #talent
November 7, 2025 at 11:13 AM
📢 #YsiosTeam | We are delighted to announce the promotion of Almudena Méndez and Sriram Balusu to #Associate at
@ysioscapital.bsky.social ! 🎉
👏 Congratulations, very well deserved!
🙋♀️ Meet Almudena lnkd.in/dSrMw4Ya
🙋 Meet Sriram: bit.ly/SriramB
#vc #talent
@ysioscapital.bsky.social ! 🎉
👏 Congratulations, very well deserved!
🙋♀️ Meet Almudena lnkd.in/dSrMw4Ya
🙋 Meet Sriram: bit.ly/SriramB
#vc #talent
#Telescope I 🔭 The Q3 report for #TelescopeBiotech, a public equities fund advised by @ysioscapital.bsky.social , is now available from our partner Andbank Wealth Management.
👉Full report - andbank.es/boutiquehub/...
#PublicEquity #Fund #healthcareInvesting #BiotechSector
👉Full report - andbank.es/boutiquehub/...
#PublicEquity #Fund #healthcareInvesting #BiotechSector
November 7, 2025 at 11:08 AM
#Telescope I 🔭 The Q3 report for #TelescopeBiotech, a public equities fund advised by @ysioscapital.bsky.social , is now available from our partner Andbank Wealth Management.
👉Full report - andbank.es/boutiquehub/...
#PublicEquity #Fund #healthcareInvesting #BiotechSector
👉Full report - andbank.es/boutiquehub/...
#PublicEquity #Fund #healthcareInvesting #BiotechSector
#Speaker I Terminamos el día con nuestra analista Malgorzata Rogalska en el panel “Due Diligence Decoded: Diving into VC, CVC, and Pharma Practices”
Programa completo 👉https://buff.ly/ajutCuH
#BioSpain2025 #vc
Programa completo 👉https://buff.ly/ajutCuH
#BioSpain2025 #vc
October 8, 2025 at 12:00 PM
#Speaker I Terminamos el día con nuestra analista Malgorzata Rogalska en el panel “Due Diligence Decoded: Diving into VC, CVC, and Pharma Practices”
Programa completo 👉https://buff.ly/ajutCuH
#BioSpain2025 #vc
Programa completo 👉https://buff.ly/ajutCuH
#BioSpain2025 #vc
#Speaker I Seguimos ahora con nuestro Partner Thomas Harth en el panel “Science Meets Capital: De-risking Early Biotech to Unlock Investment”
Programa completo 👉https://amconferences.eventsair.com/QuickEventWebsitePortal/biospain-2025/program/Agenda
#BioSpain2025 #vc
Programa completo 👉https://amconferences.eventsair.com/QuickEventWebsitePortal/biospain-2025/program/Agenda
#BioSpain2025 #vc
October 8, 2025 at 9:28 AM
#Speaker I Seguimos ahora con nuestro Partner Thomas Harth en el panel “Science Meets Capital: De-risking Early Biotech to Unlock Investment”
Programa completo 👉https://amconferences.eventsair.com/QuickEventWebsitePortal/biospain-2025/program/Agenda
#BioSpain2025 #vc
Programa completo 👉https://amconferences.eventsair.com/QuickEventWebsitePortal/biospain-2025/program/Agenda
#BioSpain2025 #vc
#Speaker I Hoy, nuestro Partner Guillem Laporta
participa en "The Role of Biotechnology in the Pharmaceutical Industry: Present and Future Perspectives"
Programa completo 👉https://amconferences.eventsair.com/QuickEventWebsitePortal/biospain-2025/program/Agenda
#BioSpain2025 #vc
participa en "The Role of Biotechnology in the Pharmaceutical Industry: Present and Future Perspectives"
Programa completo 👉https://amconferences.eventsair.com/QuickEventWebsitePortal/biospain-2025/program/Agenda
#BioSpain2025 #vc
October 8, 2025 at 9:26 AM
#Speaker I Hoy, nuestro Partner Guillem Laporta
participa en "The Role of Biotechnology in the Pharmaceutical Industry: Present and Future Perspectives"
Programa completo 👉https://amconferences.eventsair.com/QuickEventWebsitePortal/biospain-2025/program/Agenda
#BioSpain2025 #vc
participa en "The Role of Biotechnology in the Pharmaceutical Industry: Present and Future Perspectives"
Programa completo 👉https://amconferences.eventsair.com/QuickEventWebsitePortal/biospain-2025/program/Agenda
#BioSpain2025 #vc
#Speaker I Hoy, nuestro Managing Partner Joë Jean-Mairet
participa en "Guest Nation Switzerland: Entangling the Swiss and Spanish Biotech Ecosystems"
Programa completo 👉 amconferences.eventsair.com/QuickEventWe...
#BioSpain2025 #vc
participa en "Guest Nation Switzerland: Entangling the Swiss and Spanish Biotech Ecosystems"
Programa completo 👉 amconferences.eventsair.com/QuickEventWe...
#BioSpain2025 #vc
October 7, 2025 at 10:34 AM
#Speaker I Hoy, nuestro Managing Partner Joë Jean-Mairet
participa en "Guest Nation Switzerland: Entangling the Swiss and Spanish Biotech Ecosystems"
Programa completo 👉 amconferences.eventsair.com/QuickEventWe...
#BioSpain2025 #vc
participa en "Guest Nation Switzerland: Entangling the Swiss and Spanish Biotech Ecosystems"
Programa completo 👉 amconferences.eventsair.com/QuickEventWe...
#BioSpain2025 #vc
#YsiosTeam I 🎉 Excited to announce Laura Argelich's promotion to #Associate at #YsiosCapital!
👏Congrats Laura, well deserved!
🔗Full profile ysioscapital.com/team/laura-a...
#vc #talent
👏Congrats Laura, well deserved!
🔗Full profile ysioscapital.com/team/laura-a...
#vc #talent
September 30, 2025 at 1:01 PM
#YsiosTeam I 🎉 Excited to announce Laura Argelich's promotion to #Associate at #YsiosCapital!
👏Congrats Laura, well deserved!
🔗Full profile ysioscapital.com/team/laura-a...
#vc #talent
👏Congrats Laura, well deserved!
🔗Full profile ysioscapital.com/team/laura-a...
#vc #talent
#PortfolioNews I Study shows that #MAFTest® developed by our #portfolio company #Ibiomotion may save €105M in early #breast #cancer care.
🔗 Press release - buff.ly/8pAhrip
📄 Full publication here: lnkd.in/d3aUWmpp
#Oncology #HealthEconomics #BreastCancer
🔗 Press release - buff.ly/8pAhrip
📄 Full publication here: lnkd.in/d3aUWmpp
#Oncology #HealthEconomics #BreastCancer
September 18, 2025 at 1:44 PM
#PortfolioNews I Study shows that #MAFTest® developed by our #portfolio company #Ibiomotion may save €105M in early #breast #cancer care.
🔗 Press release - buff.ly/8pAhrip
📄 Full publication here: lnkd.in/d3aUWmpp
#Oncology #HealthEconomics #BreastCancer
🔗 Press release - buff.ly/8pAhrip
📄 Full publication here: lnkd.in/d3aUWmpp
#Oncology #HealthEconomics #BreastCancer
Reposted by Ysios Capital Partners
El fons d'inversió Ysios Capital ha tancat un acord de compravenda amb la multinacional suïssa CSL per un preu màxim de 2.200 milions de dòlars (uns 1.862 milions d&...
Ysios tanca un acord de venda d'una 'start-up' per un màxim de 1.862 M€
La companyia participada pel fons d'inversió està desenvolupant un tractament contra les hemorràgies
www.ara.cat
September 16, 2025 at 12:33 PM
El fons d'inversió Ysios Capital ha tancat un acord de compravenda amb la multinacional suïssa CSL per un preu màxim de 2.200 milions de dòlars (uns 1.862 milions d&...
Reposted by Ysios Capital Partners
🧪 #Barcelona consolida su papel como hub emergente en ciencias de la vida con una operación internacional de gran impacto: Ysios Capital ha anunciado una alianza estratégica entre su participada VarmX y la farmacéutica australiana CSL
✍️ Elena Busquets
✍️ Elena Busquets
El papel de Barcelona en la macrooperación biomédica de VarmX y CSL, valorada en hasta 2.200 millones de dólares
Ysios Capital anuncia un acuerdo estratégico de desarrollo de un medicamento con opción de compra de su participada VarmX
www.thenewbarcelonapost.com
September 16, 2025 at 2:45 PM
🧪 #Barcelona consolida su papel como hub emergente en ciencias de la vida con una operación internacional de gran impacto: Ysios Capital ha anunciado una alianza estratégica entre su participada VarmX y la farmacéutica australiana CSL
✍️ Elena Busquets
✍️ Elena Busquets
📢 #PortfolioNews | Excited to share the strategic deal of our #portfolio company #VarmX with #CSL 💊
🔹Up to $2.2B incl. $117m upfront & milestones
🔹Global Phase 3 of VMX-C001 fully funded
🌍Step closer to market for a major unmet need
👉 buff.ly/aO4iHwV
#YsiosPortfolio #vc
🔹Up to $2.2B incl. $117m upfront & milestones
🔹Global Phase 3 of VMX-C001 fully funded
🌍Step closer to market for a major unmet need
👉 buff.ly/aO4iHwV
#YsiosPortfolio #vc
September 16, 2025 at 10:08 AM
📢 #PortfolioNews | Excited to share the strategic deal of our #portfolio company #VarmX with #CSL 💊
🔹Up to $2.2B incl. $117m upfront & milestones
🔹Global Phase 3 of VMX-C001 fully funded
🌍Step closer to market for a major unmet need
👉 buff.ly/aO4iHwV
#YsiosPortfolio #vc
🔹Up to $2.2B incl. $117m upfront & milestones
🔹Global Phase 3 of VMX-C001 fully funded
🌍Step closer to market for a major unmet need
👉 buff.ly/aO4iHwV
#YsiosPortfolio #vc
#PortfolioNews I MAF Test® now adopted in top #Spanish hospitals to personalize early-stage #breast #cancer treatment. A major step for our #portfolio company #Inbiomotion !
👉 Full details here - buff.ly/aT4nwud
#BreastCancer #Oncology #PortfolioNews #MAFTest
👉 Full details here - buff.ly/aT4nwud
#BreastCancer #Oncology #PortfolioNews #MAFTest
July 18, 2025 at 11:27 AM
#PortfolioNews I MAF Test® now adopted in top #Spanish hospitals to personalize early-stage #breast #cancer treatment. A major step for our #portfolio company #Inbiomotion !
👉 Full details here - buff.ly/aT4nwud
#BreastCancer #Oncology #PortfolioNews #MAFTest
👉 Full details here - buff.ly/aT4nwud
#BreastCancer #Oncology #PortfolioNews #MAFTest
#Press I 🚀¿Qué hay detrás del boom #emprendedor en #Barcelona? Fondos como @ysioscapital.bsky.social lo analizan en este artículo de @thenewbcnpost.bsky.social. No te lo pierdas!
👉 www.thenewbarcelonapost.com/el-tejido-in...
#vc #biotech
👉 www.thenewbarcelonapost.com/el-tejido-in...
#vc #biotech
El tejido inversor como combustible para la Barcelona emprendedora
Con un ecosistema maduro, la capital catalana vive la irrupción de nuevos fondos locales y capta la atención de actores internacionales, posicionada como el principal 'hub' emprendedor del sur de Euro...
www.thenewbarcelonapost.com
July 1, 2025 at 9:05 AM
#Press I 🚀¿Qué hay detrás del boom #emprendedor en #Barcelona? Fondos como @ysioscapital.bsky.social lo analizan en este artículo de @thenewbcnpost.bsky.social. No te lo pierdas!
👉 www.thenewbarcelonapost.com/el-tejido-in...
#vc #biotech
👉 www.thenewbarcelonapost.com/el-tejido-in...
#vc #biotech
#PODCAST I 🎙️ Inside Spain’s biggest biotech Series B ever: €119M for SpliceBio
🧬Hear how they built it from scratch, scaled fast & made history.
With CEO Miquel Vila-Perelló & @jordixiol.bsky.social (Ysios Capital).
🎧 buff.ly/Cl9x8vL
#YsiosPodcast #BiotechPillsWithJordi #vc
🧬Hear how they built it from scratch, scaled fast & made history.
With CEO Miquel Vila-Perelló & @jordixiol.bsky.social (Ysios Capital).
🎧 buff.ly/Cl9x8vL
#YsiosPodcast #BiotechPillsWithJordi #vc
June 25, 2025 at 10:58 AM
#PODCAST I 🎙️ Inside Spain’s biggest biotech Series B ever: €119M for SpliceBio
🧬Hear how they built it from scratch, scaled fast & made history.
With CEO Miquel Vila-Perelló & @jordixiol.bsky.social (Ysios Capital).
🎧 buff.ly/Cl9x8vL
#YsiosPodcast #BiotechPillsWithJordi #vc
🧬Hear how they built it from scratch, scaled fast & made history.
With CEO Miquel Vila-Perelló & @jordixiol.bsky.social (Ysios Capital).
🎧 buff.ly/Cl9x8vL
#YsiosPodcast #BiotechPillsWithJordi #vc
#PortfolioNews | Proud to join the $135M Series B of our #portfolio company #SpliceBio, the largest round ever raised by a Spanish biotech 🚀
🧬 Advance SB-007 for #StargardtDisease
🔬Expand #GeneticMedicine pipeline
👉 buff.ly/jey8g9O
#VC #Biotech #Innovation #ProteinSplicing
🧬 Advance SB-007 for #StargardtDisease
🔬Expand #GeneticMedicine pipeline
👉 buff.ly/jey8g9O
#VC #Biotech #Innovation #ProteinSplicing
June 11, 2025 at 9:16 AM
#PortfolioNews | Proud to join the $135M Series B of our #portfolio company #SpliceBio, the largest round ever raised by a Spanish biotech 🚀
🧬 Advance SB-007 for #StargardtDisease
🔬Expand #GeneticMedicine pipeline
👉 buff.ly/jey8g9O
#VC #Biotech #Innovation #ProteinSplicing
🧬 Advance SB-007 for #StargardtDisease
🔬Expand #GeneticMedicine pipeline
👉 buff.ly/jey8g9O
#VC #Biotech #Innovation #ProteinSplicing
📰 #PRESS I Ysios Capital abre una nueva etapa con #Telescope y mira a la transferencia tecnológica.
🔗 buff.ly/z6H7Zpt
More info 👉 buff.ly/btsAIE6
cc/ #Andbank
#vc #fund #NasdaqListed
🔗 buff.ly/z6H7Zpt
More info 👉 buff.ly/btsAIE6
cc/ #Andbank
#vc #fund #NasdaqListed
Ysios Capital abre una nueva etapa con Telescope y mira a la transferencia tecnológica
La gestora de capital riesgo se alía con Andbank para invertir en una veintena de compañías 'biotech' que cotizen en EE.UU.
buff.ly
May 28, 2025 at 7:48 AM
📰 #PRESS I Ysios Capital abre una nueva etapa con #Telescope y mira a la transferencia tecnológica.
🔗 buff.ly/z6H7Zpt
More info 👉 buff.ly/btsAIE6
cc/ #Andbank
#vc #fund #NasdaqListed
🔗 buff.ly/z6H7Zpt
More info 👉 buff.ly/btsAIE6
cc/ #Andbank
#vc #fund #NasdaqListed
🚀 ¡Enhorabuena a nuestra analista @mrogalska.bsky.social , finalista del Premio Vanguardia de la Ciencia 2025 por su trabajo en el @crg.eu sobre el #espliceosoma humano!
📰 buff.ly/68bKHZS
👏 Orgullosos de contar con su talento en Ysios.
#MujeresEnCiencia #YsiosTeam
📰 buff.ly/68bKHZS
👏 Orgullosos de contar con su talento en Ysios.
#MujeresEnCiencia #YsiosTeam
Cómo se editan los genes en el cuerpo humano
El genoma dice qué genes tenemos; el proteoma, qué proteínas producimos. Pero entre ambos se encuentra el espliceosoma, una maquinaria molecular esencial para editar
buff.ly
May 27, 2025 at 10:32 AM
🚀 ¡Enhorabuena a nuestra analista @mrogalska.bsky.social , finalista del Premio Vanguardia de la Ciencia 2025 por su trabajo en el @crg.eu sobre el #espliceosoma humano!
📰 buff.ly/68bKHZS
👏 Orgullosos de contar con su talento en Ysios.
#MujeresEnCiencia #YsiosTeam
📰 buff.ly/68bKHZS
👏 Orgullosos de contar con su talento en Ysios.
#MujeresEnCiencia #YsiosTeam
#Speaker | Don’t miss Karen Wagner at #SwissHLG today at 13:35 !
🎤 "Managing a portfolio of minority stakes – the view from venture capital"
#VC #Biotech #PharmaDeals #LifeSciences
🎤 "Managing a portfolio of minority stakes – the view from venture capital"
#VC #Biotech #PharmaDeals #LifeSciences
May 26, 2025 at 10:11 AM
#Speaker | Don’t miss Karen Wagner at #SwissHLG today at 13:35 !
🎤 "Managing a portfolio of minority stakes – the view from venture capital"
#VC #Biotech #PharmaDeals #LifeSciences
🎤 "Managing a portfolio of minority stakes – the view from venture capital"
#VC #Biotech #PharmaDeals #LifeSciences
Reposted by Ysios Capital Partners
🔬 En 2024, nacieron un 24% menos bebés que hace 10 años. Un cambio demográfico que responde a varios factores, como el aumento de la infertilidad. Para abordar este fenómeno, ReproNovo ha cerrado una ronda de 65 millones de dólares
✍ Ainara Valadez
✍ Ainara Valadez
ReproNovo levanta 65 millones de dólares para desarrollar terapias para la infertilidad
La ronda de financiación ha sido liderada por Jeito Capital, con la participación de AXA IM Alts, M Ventures, ALSA Ventures e Ysios Capital
www.thenewbarcelonapost.com
May 21, 2025 at 2:12 PM
🔬 En 2024, nacieron un 24% menos bebés que hace 10 años. Un cambio demográfico que responde a varios factores, como el aumento de la infertilidad. Para abordar este fenómeno, ReproNovo ha cerrado una ronda de 65 millones de dólares
✍ Ainara Valadez
✍ Ainara Valadez
Reposted by Ysios Capital Partners
La biofarmacéutica suiza ReproNovo capta unos 57 millones de euros y abrirá sede en Barcelona
La biofarmacéutica suiza ReproNovo capta unos 57 millones de euros y abrirá sede en Barcelona
www.elperiodico.com
May 21, 2025 at 5:15 AM
La biofarmacéutica suiza ReproNovo capta unos 57 millones de euros y abrirá sede en Barcelona
📢 We’re proud to join the $65M Series A of #ReproNovo, advancing Phase 2 therapies in #ReproductiveMedicine & #WomensHealth
🔬Two lead assets:
🔹RPN001 – male infertility
🔹RPN002 – adenomyosis & ART
First step into this space for Ysios Capital
👉https://buff.ly/oHEegkT
#vc
🔬Two lead assets:
🔹RPN001 – male infertility
🔹RPN002 – adenomyosis & ART
First step into this space for Ysios Capital
👉https://buff.ly/oHEegkT
#vc
May 21, 2025 at 9:17 AM
📢 We’re proud to join the $65M Series A of #ReproNovo, advancing Phase 2 therapies in #ReproductiveMedicine & #WomensHealth
🔬Two lead assets:
🔹RPN001 – male infertility
🔹RPN002 – adenomyosis & ART
First step into this space for Ysios Capital
👉https://buff.ly/oHEegkT
#vc
🔬Two lead assets:
🔹RPN001 – male infertility
🔹RPN002 – adenomyosis & ART
First step into this space for Ysios Capital
👉https://buff.ly/oHEegkT
#vc
#Congress | Join us this week at 𝗕𝗶𝗼€q𝘂𝗶𝘁𝘆 𝗘𝘂𝗿𝗼𝗽𝗲 2025 in Bruges! 🙋♂️🙋♀️Joël Jean-Mairet, Karen Wagner, Thomas Harth, Laura Argelich, Sriram Balusu.
🎯Excited to be back at this leading event for biotech investors.
#BioequityEurope #BEE25 #Biotech #VentureCapital
🎯Excited to be back at this leading event for biotech investors.
#BioequityEurope #BEE25 #Biotech #VentureCapital
May 13, 2025 at 11:01 AM
#Congress | Join us this week at 𝗕𝗶𝗼€q𝘂𝗶𝘁𝘆 𝗘𝘂𝗿𝗼𝗽𝗲 2025 in Bruges! 🙋♂️🙋♀️Joël Jean-Mairet, Karen Wagner, Thomas Harth, Laura Argelich, Sriram Balusu.
🎯Excited to be back at this leading event for biotech investors.
#BioequityEurope #BEE25 #Biotech #VentureCapital
🎯Excited to be back at this leading event for biotech investors.
#BioequityEurope #BEE25 #Biotech #VentureCapital
#Speaker I 🎤 Don’t miss Karen Wagner today at #SwissBiotechDay — 12:00 in Room Verseau!
"Bridging Borders: Cross-Border Partnering in Biotech"
#VC #Biotech #GlobalDeals
"Bridging Borders: Cross-Border Partnering in Biotech"
#VC #Biotech #GlobalDeals
May 6, 2025 at 8:27 AM
#Speaker I 🎤 Don’t miss Karen Wagner today at #SwissBiotechDay — 12:00 in Room Verseau!
"Bridging Borders: Cross-Border Partnering in Biotech"
#VC #Biotech #GlobalDeals
"Bridging Borders: Cross-Border Partnering in Biotech"
#VC #Biotech #GlobalDeals
Reposted by Ysios Capital Partners
💡Com hauria de ser un fons de transferència tecnològica i de creació d’spin-offs biotecnològiques?
🗣️Joël Jean-Mairet, Managing Partner d’@ysioscapital.bsky.social ha compartit el model d’èxit que utilitzen per invertir en projectes científics i acompanyar-los fins a la creació d'empreses
🗣️Joël Jean-Mairet, Managing Partner d’@ysioscapital.bsky.social ha compartit el model d’èxit que utilitzen per invertir en projectes científics i acompanyar-los fins a la creació d'empreses
April 24, 2025 at 10:57 AM
💡Com hauria de ser un fons de transferència tecnològica i de creació d’spin-offs biotecnològiques?
🗣️Joël Jean-Mairet, Managing Partner d’@ysioscapital.bsky.social ha compartit el model d’èxit que utilitzen per invertir en projectes científics i acompanyar-los fins a la creació d'empreses
🗣️Joël Jean-Mairet, Managing Partner d’@ysioscapital.bsky.social ha compartit el model d’èxit que utilitzen per invertir en projectes científics i acompanyar-los fins a la creació d'empreses
#PortfolioNews | #SparingVision receives #FDA support to launch Phase II trial of SPVN06 in #GeographicAtrophy
🎯 #GA is an advanced form of dry age-related macular degeneration (dAMD) that leads to progressive and irreversible vision loss
👉 buff.ly/m0BlGti
#GeneTherapy
🎯 #GA is an advanced form of dry age-related macular degeneration (dAMD) that leads to progressive and irreversible vision loss
👉 buff.ly/m0BlGti
#GeneTherapy
April 22, 2025 at 2:44 PM
#PortfolioNews | #SparingVision receives #FDA support to launch Phase II trial of SPVN06 in #GeographicAtrophy
🎯 #GA is an advanced form of dry age-related macular degeneration (dAMD) that leads to progressive and irreversible vision loss
👉 buff.ly/m0BlGti
#GeneTherapy
🎯 #GA is an advanced form of dry age-related macular degeneration (dAMD) that leads to progressive and irreversible vision loss
👉 buff.ly/m0BlGti
#GeneTherapy